LYVE1 and myocardial infarction: Immunohistochemical staining showed that the increased number of von Willebrand factor positive (vWF+) endothelial cells (Figure 6C) and the LYVE1+ lymphatic vessels (Figure 6D) in the hEPvec‐treated MI hearts were attenuated in the hEPshITLN1‐treated group.